Tildrakizumab for Psoriasis in Patients With Current or Prior Malignancy: Methodological Considerations and Clinical Implications

International Journal of Dermatology 2026

View at publisher

Authors: Yaqing Zhao, Bangdi Chen, Lele Shen, Yi Yu, Jianyuan Xi

DOI: 10.1111/ijd.70269

Cited by: 0

References: 5

Abstract

Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.

Psoriasis: Treatment and Pathogenesis Dermatology and Skin Diseases Nonmelanoma Skin Cancer Studies

References 5